Amdipharm Mercury Company Limited DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Related Companies

Amdipharm Mercury Debtco Limited

Amdipharm Mercury (AMCo) is a fast growing international speciality pharmaceuticals company delivering high quality niche medicines to patients and healthcare authorities in 112 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group by the private equity firm Cinven. The combined businesses are highly complimentary to each other, with well established product portfolios, and provide a str...

Amdipharm Mercury (AMCo) is a fast growing international speciality pharmaceuticals company delivering high quality niche medicines to patients and healthcare authorities in 112 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group by the private equity firm Cinven. The combined businesses are highly complimentary to each other, with well established product portfolios, and provide a strong platform for future growth through acquisitions in line with Cinven's ambition to build a truly global pharmaceutical company. After the merger in early 2013, AMCo acquired global rights to Fucithalmic ® from LEO Pharma A/S and then acquired Abcur A/S in Sweden to create a direct presence in the Nordics, to complement its existing direct presence in the UK, Ireland, France and Benelux. Sales revenues in 2013 grew over 10% to circa £250m. If you would like to learn more about AMCo, its products or its people, please Contact us. We look forward to strengthening the close relationships we have forged with our existing partners and to developing prosperous relations with further partners.